Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Yale University
New Haven, Connecticut
The records below are financial disclosure and conflict of interest records obtained by ProPublica from the National Institutes of Health and dozens of large public universities across the country. The NIH only has records for researchers who seek or receive its funding.
Total Disclosures: 144
| Name | Type | Company | Disclosed Value | Year Filed |
|---|---|---|---|---|
| Willilam Tamborlane | Conflict of Interest | Medtronic Diabetese | $10,000 - $19,999 | 2014 |
| William Tamborlane | Conflict of Interest | Bristol-Myers Squibb | $10,000 - $19,999 | 2014 |
| Lieping Chen | Conflict of Interest | AstraZeneca Pharmaceuticals | $10,000 - $19,999 | 2015 |
| Frank Slack | Conflict of Interest | MiRNA Therapeutics | $10,000 - $19,999 | 2016 |
| Eroboghene E. Ubogu | Conflict of Interest | Catalyst Pharmaceutical Partners, Inc. | $10,000 - $19,999 | 2016 |
| William Tamborlane | Conflict of Interest | Takeda Pharmaceuticals | $10,000 - $19,999 | 2014 |
| William Tamborlane | Conflict of Interest | Sanofi US | $10,000 - $19,999 | 2014 |
| William Tamborlane | Conflict of Interest | Boehringer-Ingelheim | $10,000 - $19,999 | 2014 |
| Steven Gore | Conflict of Interest | Celgene Corporation | $10,000 - $19,999 | 2014 |
| Lieping Chen | Conflict of Interest | AstraZeneca Pharmaceuticals | $10,000 - $19,999 | 2014 |
| Sarah Goldberg | Conflict of Interest | AstraZeneca | $10,000 - $19,999 | 2018 |
| Willliam Tamborlane | Conflict of Interest | Bristol-Myers Squibb | $10,000 - $19,999 | 2014 |
| Mario Sznol | Conflict of Interest | Bristol Meyers Squibb, Inc. | $10,000 - $19,999 | 2012 |
| William Tamborlane | Conflict of Interest | Boehringer-Ingelheim | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Locemia Solutions | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Sanofi US | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Takeda Pharmaceuticals | $5,000 - $9,999 | 2014 |
| Stuart Weinzimer | Conflict of Interest | Insulet Corporation | $5,000 - $9,999 | 2017 |
| William Tamborlane | Conflict of Interest | Halozyme | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Thermalin | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Sanofi US | $5,000 - $9,999 | 2014 |
| William Tamborlane | Conflict of Interest | Takeda Pharmaceuticals | $5,000 - $9,999 | 2014 |
| Laura Niklason | Conflict of Interest | Humacyte, Inc. | $5,000 - $9,999 | 2016 |
| Jean-Francois Geschwind | Conflict of Interest | Philips Healthcare | $5,000 - $9,999 | 2016 |
| Alexandra Piotrowski-Daspit | Conflict of Interest | TruCode Gene Repair, Inc. | $5,000 - $9,999 | 2019 |
| Laura E. Niklason | Conflict of Interest | Humacyte, Inc. | $5,000 - $9,999 | 2016 |
| William Tamborlane | Conflict of Interest | Thermalin | $0 - $4,999 | 2014 |
| Frank Slack | Conflict of Interest | Mira Dx, Inc. | $0 - $4,999 | 2016 |
| Frank Slack | Conflict of Interest | MiRNA Therapeutics | $0 - $4,999 | 2016 |
| Williiam Tamborlane | Conflict of Interest | Thermalin | $0 - $4,999 | 2014 |
| Michael Girardi | Conflict of Interest | StraDEFY, LLC. | 2018 | |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | 2014 | |
| Samuel Katz | Conflict of Interest | Gene-in-Cell, Inc. | 2017 | |
| Donald Engelman | Conflict of Interest | pHLIP, Inc. | 2017 | |
| Donald Engelman | Conflict of Interest | pHLIP, Inc. | 2017 | |
| Marie Egan | Conflict of Interest | Tru Code (formerly PNA Innovations, Inc.) | 2017 | |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | 2014 | |
| Kathleen Carroll | Conflict of Interest | CBT4CBT, LLC | 2014 | |
| Richard Bucala | Conflict of Interest | MIFCOR, Inc. | 2015 | |
| William Tamborlane | Conflict of Interest | Patton Medical Devices | 2014 | |
| Rong Fan | Conflict of Interest | Isoplexis | 2015 | |
| William Tamborlane | Conflict of Interest | Patton Medical Devices | 2014 | |
| W. Mark Saltzman | Conflict of Interest | TruCode | 2018 | |
| Stephen Strittmatter | Conflict of Interest | Axerion Therapeutics, Inc. | 2016 | |
| William Tamborlane | Conflict of Interest | Grove Instruments | 2014 | |
| William Tamborlane | Conflict of Interest | Grove Instruments | 2014 | |
| Peter Glazer | Conflict of Interest | Cybrexa Therapeutics | 2017 | |
| Williiam Tamborlane | Conflict of Interest | Thermalin | 2014 | |
| Daniel Geschwind | Conflict of Interest | SynapDX | 2013 | |
| W. Mark Saltzman | Conflict of Interest | Nanosive | 2018 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.